Mydecine Innovations Group has been building momentum with a string of recent announcements.
Mydecine Innovations Group has been building momentum with a string of recent announcements.
Intelligent diversification is the key to investing in this emerging industry.
Red Light Holland released a detailed corporate update that includes operational and financial highlights as well as recent appointments.
Numinus is pricing its financing at CAD$0.27 per unit, with warrants priced at CAD$0.40.
Funding to evaluate the potential of psilocybin to ease end-of-life distress.
Globally, over 1 billion people are substance abusers. The U.S. addiction treatment market is already a $35 billion per year industry. Psychedelic drugs may be the (better) answer.
MagicMed Industries is seeking to raise CAD$1.5 million via the sale of 6,000,000 common shares.
Mydecine is tapping into the spiritual dimension of psychedelics with its own meditation app.
Red Light Holland places 10,000-unit order of its psychedelic truffles for distribution in the Netherlands.
Pharmadrug has completed a financial restructuring including retiring ~CAD$1.5 million in debt.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now